Oxford University to test COVID-19 vaccine response among children for first time
Administrator_India | February 15, 2021 | 0 | Coronavirus NewsBy Administrator_India
The University of Oxford has launched a study to assess the safety and immune response of the COVID-19 vaccine it has developed with AstraZeneca Plc in children for the first time, it said on Saturday.
The new mid-stage trial will determine whether the vaccine is effective on people between the ages of 6 and 17, according to an emailed statement from the university.
Around 300 volunteers will be enrolled and first inoculations are expected this month, Oxford said.
The two-dose Oxford/AstraZeneca vaccine has been hailed as a ‘vaccine for the world’ because it is cheaper and easier to distribute than some rivals.
AstraZeneca has a target to produce 3 billion doses this year and aims to produce over 200 million doses per month by April.
Related Posts
Omicron variant wipes out Delta completely…
Administrator_India | March 29, 2022 | 0The Tamil Nadu Directorate of Public health in a statement said that the Delta variant of Covid-19 is now totally replaced by the Omicron variant in the state. The report…
India logs over 3.06 lakh new…
Administrator_India | January 24, 2022 | 0India recorded 3,06,064 new Covid-19 cases and 439 related deaths in the last 24 hours, according to the Union Ministry of Health and Family Welfare on Monday. While daily cases are fewer…